Mito-metformin protects against mitochondrial dysfunction and dopaminergic neuronal degeneration by activating upstream PKD1 signaling in cell culture and MitoPark animal models of Parkinson’s disease

@cstroeckw Metformin was not well tolerated by most of our group but could Mito-metformin reduce off targets and focus on mitochondrial dysfunction? https://t.co/Gm8RMsOdqw